Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 1/2 × Urologic Diseases × B701 protein, Human herpesvirus 6 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Urologic Diseases 2 Urinary Bladder Neoplasms 2 Urinary Bladder Diseases 2 Carcinoma, Transitional Cell 2

Interventions

vofatamab 2 B701 protein, Human herpesvirus 6 2 pembrolizumab 1 Tranexamic Acid 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03123055 2020-03-18

FIERCE-22

Rainier Therapeutics

Phase 1/2 Terminated

28 enrolled 8 charts

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urologic Diseases

NCT02401542 2020-03-09

FIERCE-21

Rainier Therapeutics

Phase 1/2 Terminated

71 enrolled 9 charts

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡